From going public to navigating the pandemic, we sat down with SAB Biotherapeutics CEO Eddie Sullivan for our latest CEO Series.
From going public to navigating the pandemic, we sat down with SAB Biotherapeutics CEO Eddie Sullivan for our latest CEO Series.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed